Clinical Trials in Texas

Showing 7121-7140 of 15,101 trials

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

NCT02249104

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

Acne Vulgaris

Galderma R&D28 participantsStarted Aug 2014

Pflugerville, Texas, United States

COMPLETEDPhase 355 miles

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

NCT03960957

An interventional phase 3 study to evaluate efficacy and safety of a new dilution and injection volume of AbobotulinumtoxinA treatment for glabellar lines

Glabellar Frown Lines

Galderma R&D301 participantsStarted Jun 2019

Redondo Beach, California, United States • San Diego, California, United States • Westport, Connecticut, United States +8 more locations

COMPLETED55 miles

3T MRI CIED Post-Approval Study

NCT02969395

The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).

Cardiac Rhythm Disorder

Medtronic41 participantsStarted Apr 2016

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +201 more locations

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

3T MRI CIED Post-Approval Study

Find Trials by Condition in Texas

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

Open-Label Extension and Safety Study of Talazoparib

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis